Merck to collaborate with Ontada on data-driven cancer insights

By Jenni Spinner

- Last updated on GMT

(FatCamera/iStock via Getty Images Plus)
(FatCamera/iStock via Getty Images Plus)

Related tags Merck millipore MSD Cancer Oncology RWE RWD

Merck (known as MSD outside the US and Canada) will partner with the data insights firm on solutions that progress real-world research and innovations.

Ontada, the oncology and insights business of McKesson, has announced a strategic partnership with Merck (MSD outside the US and Canada), geared toward the development of real-world research and solutions for cancer care. The agreement reportedly enables the two firms to use real-world evidence (RWE) to generate solutions that improve patient outcomes and the quality of oncological care.

Ontada president Susan Shiff said the company brings to the table a history of community oncology experience.

With data insights from greater than 2m records available for research and more than 2,000 oncology providers, Ontada helps life sciences companies like Merck leverage real-world data (RWD) and evidence-based insights at the point of care to accelerate innovation and improve cancer therapy​,” Shiff remarked.

Merck and Ontada reportedly plan to collaborate on RWD studies, with the intent of exploring new scientific evidence, developing advanced methods, and assessing of efficiency in cancer care. 

Merck is focused on bringing excellence to RWE generation by advancing methods and applying rigorous methods to gain RWD-based insights,​” said Ravinder Dhawan, vice president and head of the Center for Observational and Real-World Evidence (CORE) of Merck Research Laboratories. “We look forward to working with Ontada on our shared purpose of improving the lives of patients with cancer.​”

Marcus Neubauer, chief medical officer of the US Oncology Network, said when organizations like Merck and Ontada work together to come up with research and care solutions, patients reap the benefits.

RWD study results build on the body of evidence that oncology providers use for treatment decision making, which leads to improvements in patient outcomes,​” Neubauer commented.

Ontada works to combine RWD and research capabilities, targeted channels to connect life sciences and providers for education and engagement, technologies suited to oncology clinicians. The company’s offerings in this sphere include iKnowMed electronic health record system and Clear Value Plus regimen support. 

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Webinars

Headlines